When comparing males and females, females had significantly higher levels of FABP4 than males in the COPD group (6.66±2.85 ng/ml compared with 4.35±2.16 ng/ml, P<0.0001; Figure 1). This evidence concerns the gene FABP4 and chronic obstructive pulmonary disease.